Showing results (171-180 of 323) with videos related to

Sort By:
Pageof 33
The Journal of Experimental Medicine|June 1, 1993
Complement-mediated adipocyte lysis by nephritic factor seraP W Mathieson, R Würzner, D B Oliveria, et al.
Vox Sanguinis|January 1, 1983
Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytesP J Lachmann, D Voak, R G Oldroyd, et al.
Clinical and Experimental Immunology|April 1, 1978
The immunogloblin nature of nephritic factor (NeF)D M Scott, N Amos, J G Sissons, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|August 18, 2000
[Multi-site pace making for dilated cardiomyopathy]J Lelakowski, J Machejek, J Majewski, et al.
Genome Medicine|May 29, 2015
JAFFA: High sensitivity transcriptome-focused fusion gene detectionNadia M Davidson, Ian J Majewski, Alicia Oshlack
Clinical and Experimental Immunology|September 1, 1992
C7 M/N protein polymorphism typing applied to inherited deficiencies of human complement proteins C6 and C7R Würzner, N Rance, P C Potter, et al.
Clinical and Experimental Immunology|July 1, 1985
Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteasesP Woo, P J Lachmann, R A Harrison, et al.
Complement (Basel, Switzerland)|January 1, 1987
Specificity of membrane complement receptor type three (CR3) for beta-glucansG D Ross, J A Cain, B L Myones, et al.
The Journal of General Virology|September 1, 1990
The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigensD Davis, B Chaudhri, D M Stephens, et al.
Clinical and Experimental Immunology|March 1, 1990
Peptide inhibitors of C3 breakdownP Peake, M Szelke, D M Jones, et al.
Pageof 33